Advocacy groups, researchers, academics and medical professionals have submitted a series of briefs in support of an effort to force the Drug Enforcement Administration (DEA) to carry out a review into psilocybin as part of a rescheduling petition. Washington State-based palliative care doctor Sunil Aggarwal recently asked a federal appeals court to vacate DEA’s rescheduling … Continue reading Advocates And Experts Join Fight Against DEA In Federal Psilocybin Rescheduling Case